[Is HBsAg loss an ideal end-point of oral antiviral therapy in chronic hepatitis B patients?]
- PMID: 25007428
- DOI: 10.4166/kjg.2014.63.5.329
[Is HBsAg loss an ideal end-point of oral antiviral therapy in chronic hepatitis B patients?]
Comment on
-
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability.Gut. 2014 Aug;63(8):1325-32. doi: 10.1136/gutjnl-2013-305517. Epub 2013 Oct 25. Gut. 2014. PMID: 24162593
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical